Organovo Holdings, Inc. (ONVO): Price and Financial Metrics

Organovo Holdings, Inc. (ONVO): $2.79

-0.11 (-3.79%)

POWR Rating

Component Grades













ONVO Stock Summary

  • The ratio of debt to operating expenses for Organovo Holdings Inc is higher than it is for about merely 0.55% of US stocks.
  • With a year-over-year growth in debt of -100%, Organovo Holdings Inc's debt growth rate surpasses merely 0% of about US stocks.
  • Revenue growth over the past 12 months for Organovo Holdings Inc comes in at -91.12%, a number that bests merely 1.26% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Organovo Holdings Inc are GRIL, RDVT, FN, DHIL, and AQMS.
  • ONVO's SEC filings can be seen here. And to visit Organovo Holdings Inc's official web site, go to

ONVO Stock Price Chart Interactive Chart >

Price chart for ONVO

ONVO Price/Volume Stats

Current price $2.79 52-week high $23.92
Prev. close $2.90 52-week low $2.71
Day low $2.71 Volume 86,200
Day high $3.01 Avg. volume 71,957
50-day MA $4.30 Dividend yield N/A
200-day MA $6.80 Market Cap 24.29M

Organovo Holdings, Inc. (ONVO) Company Bio

Organovo Holdings, Inc. focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company was founded in 2007 and is based in San Diego, California.

ONVO Latest News Stream

Event/Time News Detail
Loading, please wait...

ONVO Latest Social Stream

Loading social stream, please wait...

View Full ONVO Social Stream

Latest ONVO News From Around the Web

Below are the latest news stories about Organovo Holdings Inc that investors may wish to consider to help them evaluate ONVO as an investment opportunity.

Organovo Files Counterclaims In Patent Lawsuit Brought Against It by CellInk

SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today released its first detailed response to the lawsuit Cellink (NASDAQ Stockholm: BICO) filed against it in Delaware court in 2021. At issue in this lawsuit is whether Cellink is infringing Organovo patents. Organovo, as one of the earliest and most prominent 3D bioprinting companies, has built a strong and foundational patent portfolio in the space. Organovo believes that Cellink, as a newer company with lim

Yahoo | January 10, 2022

Here's Why We're Not Too Worried About Organovo Holdings' (NASDAQ:ONVO) Cash Burn Situation

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although

Yahoo | December 30, 2021

Global 4D Printing In Healthcare Market: Emerging Trends, Major Key Players 3D Systems, Inc and Organovo Holdings Inc

According to the report, The global 4D Printing in the Healthcare market size is expected to reach $50.76 Billion by 2028 growing at the CAGR of 27.71% from 2021 to 2028. The major driver for the 4D printing industry in

OpenPR | December 23, 2021

Credit Suisse AG Buys Shares of 15,607 Organovo Holdings, Inc. (NASDAQ:ONVO)

Credit Suisse AG acquired a new position in shares of Organovo Holdings, Inc. (NASDAQ:ONVO) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 15,607 shares of the medical research companys stock, valued at approximately $147,000. Credit Suisse AG owned 0.18% of Organovo at the end []

Dakota Financial News | December 3, 2021

Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022

SAN DIEGO, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), today provided a business overview and progress update, and announced it is on track to establish its first models of inflammatory bowel disease in 2022 using its 3D bioprinting and other 3D tissue technologies.

Intrado Digital Media | November 30, 2021

Read More 'ONVO' Stories Here

ONVO Price Returns

1-mo N/A
3-mo -54.63%
6-mo -63.29%
1-year -80.45%
3-year -86.19%
5-year -96.00%
YTD -23.14%
2021 -70.49%
2020 72.90%
2019 -62.95%
2018 -28.36%
2017 -60.47%

Continue Researching ONVO

Here are a few links from around the web to help you further your research on Organovo Holdings Inc's stock as an investment opportunity:

Organovo Holdings Inc (ONVO) Stock Price | Nasdaq
Organovo Holdings Inc (ONVO) Stock Quote, History and News - Yahoo Finance
Organovo Holdings Inc (ONVO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8398 seconds.